To be successful, sinus surgery must include having the patient return to nasal breathing as soon as possible after surgery, particularly when nasal packing is necessary.
Patients who continue to habitually mouth breathe following surgery may suffer from reinfection of the sinus cavities and complain the treatment failed them.
Controlling involuntary mouth breathing during sleep is a major step towards reinstating nasal breathing.
sleepQ+ is an effective and safe way to help patients maintain nasal breathing all night to reinstate nasal breathing following sinus surgery.
Two specific studies evaluating the safety of sleepQ+ for use in humans have been performed.
Sensitivity and Irritation – 54 subjects. Skin Patch Sensitivity Study by Cantor Research Laboratories Inc of Blauvelt, NY, USA following the principles referenced in “Appraisal of the Safety of Chemicals in Food, Drugs and Cosmetics” published by the US FDA. No adverse reactions of any kind were observed during the course of the study. It was concluded that the reversible oral adhesive gel is a non-primary irritant and a non-primary sensitizer.
Toxicity Study – by AMS Laboratories Pty Ltd of Silverwater NSW Australia according to ISO 10993-5 (2002) and AS/NZS 26961996) The reversible oral adhesive gel was found to be non-cytotoxic.
sleepQ+ is made in the US to FDA manufacturing standards and is registered with the Australian Therapeutic Goods Administration (TGA), Health Canada and Medsafe New Zealand for preventing involuntary mouth breathing during sleep.
Updated 1st September 2021